Autonomous metal-organic framework nanorobots for active mitochondria-targeted cancer therapy
Science Advances · 09.06.2023 · 9 (23)
DOI: 10.1126/sciadv.adh1736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 09.06.2023. Verfasst von Xiqi Peng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Luohu Clinical Institute of Shantou University Medical College, Shantou University Medical College, Shantou 515000, P. R. China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Nanorobotic manipulation to access subcellular organelles remains unmet due to the challenge in achieving intracellular controlled propulsion. Intracellular organelles, such as mitochondria, are an emerging therapeutic target with selective targeting and curative efficacy. We report an autonomous nanorobot capable of active mitochondria-targeted drug delivery, prepared by facilely encapsulating mitochondriotropic doxorubicin-triphenylphosphonium (DOX-TPP) inside zeolitic imidazolate framework-67 (ZIF-67) nanoparticles. The catalytic ZIF-67 body can decompose bioavailable hydrogen peroxide overexpressed inside tumor cells to generate effective intracellular mitochondriotropic movement in the presence of TPP cation. This nanorobot-enhanced targeted drug delivery induces mitochondria-mediated apoptosis and mitochondrial dysregulation to improve the in vitro anticancer effect and suppression of cancer cell metastasis, further verified by in vivo evaluations in the subcutaneous tumor model and orthotopic breast tumor model. This nanorobot unlocks a fresh field of nanorobot operation with intracellular organelle access, thereby introducing the next generation of robotic medical devices with organelle-level resolution for precision therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Luohu Clinical Institute of Shantou University Medical College, Shantou University Medical College, Shantou 515000, P. R. China.
- Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen 518000, P. R. China.
- Andrew and Peggy Cherng Department of Medical Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
- School of Biomedical Engineering, Health Science Centre, Shenzhen University, Shenzhen 518060, P. R. China.
- Department of Urology, South China Hospital, Medical School, Shenzhen University, Shenzhen 518116, P. R. China.
ORCID-Profile: Xiqi Peng, Songsong Tang, Yangyang Li, Heather Lukas, Hong Han, Xueji Zhang, Wei Gao, Song Wu
Zitieren
APA
Peng, X., Tang, S., Tang, D., Zhou, D., Li, Y., Chen, Q., Wan, F., Lukas, H., Han, H., Zhang, X., Gao, W., & Wu, S. (2023). Autonomous metal-organic framework nanorobots for active mitochondria-targeted cancer therapy. Science Advances, 9(23). https://doi.org/10.1126/sciadv.adh1736
Vancouver
Peng X, Tang S, Tang D, Zhou D, Li Y, Chen Q, et al. Autonomous metal-organic framework nanorobots for active mitochondria-targeted cancer therapy. Science Advances. 2023;9(23). doi:10.1126/sciadv.adh1736
BibTeX
@article{Peng2023,
author = {Peng, Xiqi and Tang, Songsong and Tang, Daitian and Zhou, Dewang and Li, Yangyang and Chen, Qiwei and Wan, Fangchen and Lukas, Heather and Han, Hong and Zhang, Xueji and Gao, Wei and Wu, Song},
title = {Autonomous metal-organic framework nanorobots for active mitochondria-targeted cancer therapy},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {23},
doi = {10.1126/sciadv.adh1736}
}
EUVIMED